Antitrust Division may block depositions in Teva securities suit, court says

A Connecticut federal judge has said the Department of Justice can intervene in private litigation against Teva Pharmaceuticals, accepting the Antitrust Division’s arguments that certain depositions and discovery could compromise the integrity of its investigation into price-fixing in the generic pharmaceuticals industry.


Get unlimited access to all Global Competition Review content